Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GLS | O94925 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12223397 | 1.00 | CA12 (0.54) | CA12CA9CA2CASP3ALDH1A1 | |
| SCHEMBL10237149 | 1.00 | CA12 (0.54) | CA12CA9CA2CASP3ALDH1A1 | |
| SCHEMBL8950475 | 0.87 | CASP3 (0.60) | CA12CA9CASP3ALDH1A1GLS | |
| SCHEMBL4468251 | 0.87 | CASP3 (0.60) | CA12CA9CASP3ALDH1A1GLS | |
| SCHEMBL4476083 | 0.87 | CASP3 (0.60) | CA12CA9CASP3ALDH1A1GLS | |
| SCHEMBL8083226 | 0.87 | CASP3 (0.49) | CA12CA9CA2CASP3ALDH1A1 | |
| SCHEMBL8083231 | 0.87 | CASP3 (0.49) | CA12CA9CA2CASP3ALDH1A1 | |
| SCHEMBL18348911 | 0.84 | TERT (0.47) | CA12CA9CA2CASP3ALDH1A1 | |
| SCHEMBL5394867 | 0.83 | CASP3 (0.56) | CA12CA9CASP3ALDH1A1GLS | |
| SCHEMBL12439955 | 0.82 | CASP3 (0.51) | CA12CA9CASP3ALDH1A1GLS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1713790-A2 | METHOD OF PREPARATION OF BENZOFURAN-2-CARBOXYLIC ACID (S)-3-METHYL-1- ((4S, 7R)-7METHYL-3-OXO-1-(PYRIDINE-2-SULFONYL)-AZ EPAN-4-YLCARBAMOYL-BUTYL)-AMIDE | SMITHKLINE BEECHAM CORPORATION (US) | 2006-10-25 | — | — | EP | claimed |
| WO-2005069981-A2 | METHOD OF PREPARATION OF BENZOFURAN-2-CARBOXYLIC ACID {(S)-3-METHYL-1-[(4S, 7R)-7METHYL-3-OXO-1-(PYRIDINE-2-SULFONYL)-AZEPAN-4-YLCARBAMOYL]-BUTYL}-AMIDE | SMITHKLINE BEECHAM CORPORATION (US) | 2005-08-04 | — | — | WO | claimed |
| CN-117263785-A | Method for linear chain selective hydroformylation of olefin by palladium catalysis | 常州大学 | 2023-12-22 | — | — | CN | disclosed |
| EP-4003952-A1 | DIFLUOROHALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES, METHODS OF PREPARATION, AND USES THEREOF | Pharmaxis Ltd. (AU) | 2022-06-01 | — | — | EP | disclosed |
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | SOOCHOW UNIVERSITY (CN) | 2022-04-28 | — | — | US | disclosed |
| CN-110078762-B | Method for preparing beta-mercapto phosphonyl derivatives | 苏州大学 | 2021-12-10 | — | — | CN | disclosed |
| CN-110105387-B | Preparation methodβProcess for preparing phosphono-sulfonic acid derivatives | 苏州大学 | 2021-12-10 | — | — | CN | disclosed |
| US-10800679-B2 | Fluidized bed and hybrid suspension electrodes for energy storage and water desalination systems | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2020-10-13 | — | — | US | disclosed |
| US-20190152811-A1 | FLUIDIZED BED AND HYBRID SUSPENSION ELECTRODES FOR ENERGY STORAGE AND WATER DESALINATION SYSTEMS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2019-05-23 | — | — | US | disclosed |
| CN-102264733-A | novel dopamine D3 receptor ligand, preparation method and medical application thereof | — | 2011-11-30 | — | — | CN | disclosed |
| US-7238795-B2 | Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-5061795-A | ANTITUMOR AGENTS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1991-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | AOC1, AOC2, AOC3 | CA12 481/4885CA9 827/4885CA2 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.